Cardiovascular Medicine Section and Myocardial Biology Unit, Boston University Medical Center, Boston, Mass 02118, USA.
Circ Heart Fail. 2010 Mar;3(2):306-13. doi: 10.1161/CIRCHEARTFAILURE.109.864785. Epub 2009 Dec 16.
BACKGROUND: Although it seems that reactive oxygen species contribute to chronic myocardial remodeling, questions remain about (1) the specific types of reactive oxygen species involved, (2) the role of reactive oxygen species in mediating specific cellular events, and (3) the cause-and-effect relationship between myocardial reactive oxygen species and the progression to heart failure. Transgenic mice with myocyte-specific overexpression of G(alpha)q develop a dilated cardiomyopathy that progresses to heart failure. We used this model to examine the role of H(2)O(2) in mediating myocardial remodeling and the progression to failure. METHODS AND RESULTS: In G(alpha)q myocardium, markers of oxidative stress were increased at 4 weeks and increased further at 20 weeks. G(alpha)q mice were crossbred with transgenic mice having myocyte-specific overexpression of catalase. At 4 weeks of age, left ventricular end-diastolic dimension was increased and left ventricular fractional shortening decreased in G(alpha)q mice and deteriorated further through 20 weeks. In G(alpha)q mice, myocardial catalase overexpression had no effect on left ventricular end-diastolic dimension or fractional shortening at 4 weeks but prevented the subsequent deterioration in both. In G(alpha)q mice, myocyte hypertrophy; myocyte apoptosis; interstitial fibrosis; and the progression to overt heart failure, as reflected by lung congestion and exercise intolerance, were prevented by catalase overexpression. CONCLUSIONS: In G(alpha)q mice, myocyte-specific overexpression of catalase had no effect on the initial phenotype of left ventricular dilation and contractile dysfunction but prevented the subsequent progressive remodeling phase leading to heart failure. Catalase prevented the cellular hallmarks of adverse remodeling (myocyte hypertrophy, myocyte apoptosis, and interstitial fibrosis) and the progression to overt heart failure. Thus, H(2)O(2), associated oxidant pathways, or both play a critical role in adverse myocardial remodeling and the progression to failure.
背景:尽管活性氧似乎会导致慢性心肌重构,但仍存在一些问题,包括(1)涉及的具体活性氧类型,(2)活性氧在介导特定细胞事件中的作用,以及(3)心肌活性氧与心力衰竭进展之间的因果关系。肌细胞特异性过表达 G(alpha)q 的转基因小鼠会发展为扩张型心肌病,并逐渐进展为心力衰竭。我们使用该模型研究了 H(2)O(2)在介导心肌重构和心力衰竭进展中的作用。
方法和结果:在 G(alpha)q 心肌中,氧化应激标志物在 4 周时增加,并在 20 周时进一步增加。G(alpha)q 小鼠与肌细胞特异性过表达过氧化氢酶的转基因小鼠进行杂交。在 4 周龄时,G(alpha)q 小鼠的左心室舒张末期内径增大,左心室缩短分数降低,并在 20 周时进一步恶化。在 G(alpha)q 小鼠中,心肌过氧化氢酶过表达在 4 周时对左心室舒张末期内径或缩短分数没有影响,但可防止随后两者的恶化。在 G(alpha)q 小鼠中,肌细胞肥大;肌细胞凋亡;间质纤维化;以及进展为明显心力衰竭,表现为肺充血和运动不耐受,均可被过氧化氢酶过表达所预防。
结论:在 G(alpha)q 小鼠中,肌细胞特异性过表达过氧化氢酶对左心室扩张和收缩功能障碍的初始表型没有影响,但可防止随后导致心力衰竭的进行性重构阶段。过氧化氢酶可预防不良重构的细胞特征(肌细胞肥大、肌细胞凋亡和间质纤维化)以及明显心力衰竭的进展。因此,H(2)O(2)、相关的氧化途径或两者都在不良心肌重构和心力衰竭进展中发挥关键作用。
Am J Physiol Heart Circ Physiol. 2014-3-14
Circulation. 1998-4-21
Cardiovasc Toxicol. 2025-6-10
J Mol Cell Cardiol Plus. 2025-4-9
Int J Health Sci (Qassim). 2024
N Engl J Med. 2008-5-15
J Mol Cell Cardiol. 2006-11
Am J Physiol Heart Circ Physiol. 2005-12
Circulation. 2005-5-31